文献速递肿瘤 PET/CT

多参数MRI与PSMA联合MRI在前列腺癌前列腺内诊断中的比较:系统评价与Meta分析

Comparison of Multiparametric MRI and the Combination of PSMA Plus MRI for the Intraprostatic Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · Clin Nucl Med · 2024-05-20

该系统评价与Meta分析共纳入19项直接比较多参数MRI(mpMRI)与前列腺特异性膜抗原(PSMA)PET联合MRI(PSMA+MRI)的研究,评估两者检测前列腺内临床显著前列腺癌(csPCa)的效能。患者水平分析显示PSMA+MRI的汇总灵敏度高于mpMRI(96% vs 89%,P=0.04),特异度无显著差异(55% vs 50%,P=0.67)。作者结论为PSMA+MRI相比mpMRI具有更优的汇总灵敏度且特异度相似。

要点

  • 患者水平PSMA+MRI检测csPCa的汇总灵敏度为96%,高于mpMRI的89%(P=0.04)。
  • 患者水平PSMA+MRI汇总特异度为55%,mpMRI为50%,两者无显著差异(P=0.67)。
  • 区域水平灵敏度PSMA+MRI为85%、mpMRI为71%(P=0.09),特异度分别为87%和90%(P=0.59)。

核心结论

  • 在直接比较研究的Meta分析中,PSMA+MRI检测csPCa的汇总灵敏度优于mpMRI,特异度相似。

研究设计与样本

  • 系统评价与Meta分析,检索相关数据库截至2023年11月,仅纳入直接比较mpMRI与PSMA+MRI(PET/MRI或PET/CT+mpMRI)的研究,共纳入19项研究。
  • 采用随机效应模型估计每种方法的汇总灵敏度、特异度和曲线下面积。

主要发现

  • 患者水平分析中,PSMA+MRI(9项研究)检测csPCa的灵敏度为96%(95%CI:92%,98%),mpMRI为89%(95%CI:81%,94%),P=0.04。
  • 患者水平分析中,PSMA+MRI(4项研究)的特异度为55%(95%CI:31%-76%),mpMRI为50%(95%CI:44%-57%),P=0.67。
  • 区域水平分析中,PSMA+MRI(10项研究)的灵敏度为85%(95%CI:74%-92%),mpMRI为71%(95%CI:58%-82%),P=0.09。
  • 区域水平分析中,PSMA+MRI(4项研究)的特异度为87%(95%CI:76%-94%),mpMRI为90%(95%CI:82%-95%),P=0.59。
  • 病灶水平灵敏度和特异度在两种方法间相似,汇总数据来自少于4项研究。

局限性

  • 病灶水平灵敏度和特异度的汇总数据来自少于4项研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to perform a head-to-head comparison of multiparametric MRI (mpMRI) and the combination of prostate-specific membrane antigen (PSMA) PET plus MRI (PSMA + MRI) for detecting intraprostatic clinically significant prostate cancer (csPCa). PATIENTS AND METHODS: Relevant databases were searched through November 2023. Only studies directly comparing mpMRI and PSMA + MRI (PET/MRI or PET/CT + mpMRI) were included. A meta-analysis with a random-effects model was used to estimate pooled sensitivity, specificity, and area under the curve for each approach. RESULTS: A total of 19 studies were included. On a patient-level analysis, PSMA + MRI had higher sensitivity (9 studies) than mpMRI for csPCa detection (96% [95% confidence interval (CI): 92%, 98%] vs 89% [95% CI: 81%, 94%]; P = 0.04). The patient-level specificity (4 studies) of PSMA + MRI was 55% (95% CI: 31%-76%) compared with 50% (95% CI: 44%-57%) of mpMRI ( P = 0.67). Region-level sensitivity (10 studies) was 85% (95% CI: 74%-92%) for PSMA + MRI and 71% (95% CI: 58%-82%) for mpMRI ( P = 0.09), whereas specificity (4 studies) was 87% (95% CI: 76%-94%) and 90% (95% CI: 82%-95%), respectively ( P = 0.59). Lesion-level sensitivity and specificity were similar between modalities with pooled data from less than 4 studies. CONCLUSIONS: PSMA + MRI had superior pooled sensitivity and similar specificity for the detection of csPCa compared with mpMRI in this meta-analysis of head-to-head studies.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Brondani Torri G, Antune Pereira P, Piovesan Wiethan C, et al. Comparison of Multiparametric MRI and the Combination of PSMA Plus MRI for the Intraprostatic Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. Clin Nucl Med. 2024. PMID: 38776063. doi:10.1097/RLU.0000000000005265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。